Stocks · Korea
476040
KOSDAQ
Organoidsciences
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+4.61%
1M+10.84%
3M-23.01%
6M-70.49%
1Y-79.86%
YTD-80.35%
52W high48,500원
52W low6,070원
From 52W high-85.03%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2025 | 24억 | -162억 | -157억 | -673.2% |
| Quarterly | ||||
| 2025 2Q | 6억 | -47억 | -45억 | -777.0% |
| 2025 3Q | 3억 | -39억 | -39억 | -1,220.6% |
| 2026 1Q | 1억 | -42억 | -44억 | -2,955.2% |
Company
Address: 충청북도 청주시 흥덕구 오송읍 오송생명2로 154 -
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| CJ 바이오사이언스 | 499억 | — | 0.93 | -4.26% |
| 데이원컴퍼니 | 453억 | 9.61 | 1.02 | +10.07% |
| 피엔케이피부임상연구센타 | 504억 | 10.37 | 0.60 | -8.30% |
| 파라택시스코리아 | 441억 | — | 1.01 | +0.00% |
| 큐라티스 | 505억 | — | 0.81 | +46.83% |
| 랩지노믹스 | 428억 | — | 0.29 | +15.40% |
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
- 2026-04-30주요사항보고서(유상증자결정) Major
- 2026-04-29주요사항보고서(전환사채권발행결정) Major
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.